Cargando…

Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients

Autologous dendritic cell (DC) therapy is an experimental cellular immunotherapy that is safe and immunogenic in patients with advanced melanoma. In an attempt to further improve the therapeutic responses, we treated 15 patients with melanoma, with autologous monocyte-derived immature DC electropora...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bol, Kalijn F, Figdor, Carl G, Aarntzen, Erik HJG, Welzen, Marieke EB, van Rossum, Michelle M, Blokx, Willeke AM, van de Rakt, Mandy WMM, Scharenborg, Nicole M, de Boer, Annemiek J, Pots, Jeanette M, olde Nordkamp, Michel AM, van Oorschot, Tom GM, Mus, Roel DM, Croockewit, Sandra AJ, Jacobs, Joannes FM, Schuler, Gerold, Neyns, Bart, Austyn, Jonathan M, Punt, Cornelis JA, Schreibelt, Gerty, de Vries, I Jolanda M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570143/ https://www.ncbi.nlm.nih.gov/pubmed/26405571 http://dx.doi.org/10.1080/2162402X.2015.1019197

Ejemplares similares

Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity
por: Bol, Kalijn F., et al.
Publicado: (2016)

Importance of helper T-cell activation in dendritic cell-based anticancer immunotherapy
por: Schreibelt, Gerty, et al.
Publicado: (2013)

Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients
por: Boudewijns, Steve, et al.
Publicado: (2016)

Early predictive value of multifunctional skin-infiltrating lymphocytes in anticancer immunotherapy
por: Wimmers, Florian, et al.
Publicado: (2014)

Reducing cell number improves the homing of dendritic cells to lymph nodes upon intradermal vaccination
por: Aarntzen, Erik HJG, et al.
Publicado: (2013)

Adjuvant dendritic cell vaccination in high-risk uveal melanoma patients
por: Bol, Kalijn, et al.
Publicado: (2015)

Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients
por: Boudewijns, Steve, et al.
Publicado: (2016)

Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E(2) results in high interleukin-12 production and cell migration
por: Boullart, A. C. Inge, et al.
Publicado: (2008)

Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
por: Boudewijns, Steve, et al.
Publicado: (2020)

T cell landscape within primary melanoma as a biomarker of survival after cancer vaccination in patients with metastatic disease
por: Vasaturo, Angela, et al.
Publicado: (2015)

A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients
por: Lesterhuis, W J, et al.
Publicado: (2010)

Immunological responses to adjuvant vaccination with combined CD1c(+) myeloid and plasmacytoid dendritic cells in stage III melanoma patients
por: Bloemendal, Martine, et al.
Publicado: (2021)

Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time
por: van Willigen, Wouter W., et al.
Publicado: (2018)

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer
por: Westdorp, Harm, et al.
Publicado: (2019)

Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets
por: Wimmers, Florian, et al.
Publicado: (2014)

Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination
por: Boudewijns, Steve, et al.
Publicado: (2016)

Immune infiltrates impact on the prediction of prognosis and response to immunotherapy of melanoma patients
por: Vasaturo, Angela, et al.
Publicado: (2015)

The clinical application of cancer immunotherapy based on naturally circulating dendritic cells
por: Bol, Kalijn F., et al.
Publicado: (2019)

BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?
por: van Ee, Thomas J., et al.
Publicado: (2018)

Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination
por: van Willigen, Wouter W., et al.
Publicado: (2020)

Intranodal Embolization for Groin Lymphocele
por: Ozawa, Mizuki, et al.
Publicado: (2021)

Insight into the dynamics, localization and magnitude of antigen-specific immune responses by [(18)F]FLT PET imaging
por: Aarntzen, Erik H.J.G., et al.
Publicado: (2012)

Learning mechanisms and outcomes of an interprofessional molecular pathology workshop for residents
por: Meeuwsen, Malon, et al.
Publicado: (2022)

A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets
por: Sittig, Simone P., et al.
Publicado: (2016)

Primary Human Blood Dendritic Cells for Cancer Immunotherapy—Tailoring the Immune Response by Dendritic Cell Maturation
por: Sittig, Simone P., et al.
Publicado: (2015)

Exercise-Induced Intranodal Atrioventricular Block
por: Park, Mi-Youn, et al.
Publicado: (2012)

Intranodal palisaded myofibroblastoma (intranodal hemorrhagic spindle cell tumor with amianthoid fibers): a case report and literature review
por: Kandemir, Nilüfer Onak, et al.
Publicado: (2010)

Mesenteric intranodal schwannoma: uncommon case of neurogenic benign tumor
por: Medina-Gallardo, Adrian, et al.
Publicado: (2017)

Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer
por: Bödder, Johanna, et al.
Publicado: (2021)

Intranodal palisaded myofibroblastoma: a case report
por: Karvouni, Helen, et al.
Publicado: (2010)

Intranodal Palisaded Myofibroblastoma: Radiological and Cytological Overview
por: Altinbas, Namik Kemal, et al.
Publicado: (2016)

Cervical intranodal schwannoma – a rare diagnosis
por: Mirea, Daniel, et al.
Publicado: (2022)

Imaging of T-cells and their responses during anti-cancer immunotherapy
por: Krekorian, Massis, et al.
Publicado: (2019)

High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer
por: Westdorp, Harm, et al.
Publicado: (2020)

Superficial basal cell carcinoma, think deeper: Step sectioning of skin biopsy specimens yields 14% more aggressive subtypes
por: El Sharouni, Mary-Ann, et al.
Publicado: (2022)

Naturally circulating dendritic cells to vaccinate cancer patients
por: Bol, Kalijn F., et al.
Publicado: (2013)

Intranodal Palisaded Myofibroblastoma in a Submandibular Lymph Node
por: Bouhajja, Leila, et al.
Publicado: (2017)

Opportunities for immunotherapy in microsatellite instable colorectal cancer
por: Westdorp, Harm, et al.
Publicado: (2016)

Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3‐dioxygenase 1 with functional effects on T cell priming
por: Sittig, Simone P., et al.
Publicado: (2021)

CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivo
por: Worbs, Tim, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_58taasimv9ub50ecrlk6tkt90o